Xeris Pharmaceuticals's total assets for Q1 2025 were $315.45M, a decrease of -2.35% from the previous quarter. XERS total liabilities were $350.58M for the fiscal quarter, a -0.59% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.